NCT02888327View on ClinicalTrials.gov

A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

May 30, 2017

Study Completion Date

May 30, 2017

Conditions
Influenza in Humans
Interventions
DRUG

AL-794

DRUG

Oseltamivir

DRUG

Digoxin

DRUG

Midazolam

DRUG

Pitavastatin

DRUG

JNJ-63623872

Trial Locations (1)

Unknown

Hammersmith Medicines Research, London

Sponsors
All Listed Sponsors
lead

Alios Biopharma Inc.

INDUSTRY